![](/img/cover-not-exists.png)
OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer
Seiwert, T Y, Foster, C C, Blair, E A, Karrison, T G, Agrawal, N, Melotek, J M, Portugal, L, Brisson, R J, Dekker, A, Kochanny, S, Gooi, Z, Lingen, M W, Villaflor, V M, Ginat, D T, Haraf, D J, Vokes,Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz171
Date:
June, 2019
File:
PDF, 70 KB
2019